Skip to main content
Log in

Pneumococcal vax cost effective with significant herd effect

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ray GT, Whitney CG, Fireman BH, Ciuryla V, Black SB.Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatric Infectious Disease Journal 25: 494-501, No. 6, Jun 2006

  2. McBean AM, Jung K, Hevert PL.Decreasing invasive pneumococcal disease in the elderly: a state-level analysis. Vaccine 24: 5609-5614, No. 27-28, 7 Jul 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pneumococcal vax cost effective with significant herd effect. Pharmacoecon. Outcomes News 509, 5 (2006). https://doi.org/10.2165/00151234-200605090-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605090-00012

Keywords

Navigation